The firm, the largest biotech company in the Philadelphia area, said it would move into leased space at the Westbrook Corporate Center rather than build a new corporate headquarters elsewhere. A $12.75 million package of grants and tax-creation credits kept Cephalon in Pennsylvania, according to the firm's CEO.

Related Summaries